International Stem Cell CORP 4
4 · International Stem Cell CORP · Filed Feb 14, 2017
Insider Transaction Report
Form 4
International Stem Cell CORPISCO.OB
Semechkin Rouslan
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2017-02-10−90,000→ 90,000 totalExercise: $1.09Exp: 2027-02-10→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]3/36th of the shares underlying such options shall vest on May 10, 2017, and the remaining share in equal monthly installments over a period of 33 months.